IP Library Granted Patent US 10,485,564
Granted Patent B2
US 10,485,564 · App. 15/377,229 · Granted Nov 26, 2019

Systems and methods to improve perfusion pressure during endovascular intervention

Inventor: Mayank Goyal (Calgary, CA)
Assignee: MG STROKE ANALYTICS INC.
A61B17/22A61M1/3659A61M5/1723A61B2017/22079A61B2017/22094A61M1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,485,564
App. No.
15/377,229
Granted
Nov 26, 2019
Kind
B2
Abstract

The invention relates to systems and methods to improve perfusion flow and pressure during endovascular intervention. In particular, the invention relates to catheters that enable both antegrade and retrograde flow through the catheter during a recanalization procedure and specifically at the step in a procedure where a clot is being withdrawn. Additionally, the invention provides systems for supplying fluids and fluid compositions to improve nutrition to ischemic brain.

Claims (27)

1. A system to maintain and/or enhance perfusion pressure in a patient with acute stroke and having relatively isolated circulation during an endovascular procedure as a catheter is advancing within the internal carotid artery, the system comprising:

a catheter adapted for placement within the internal carotid artery, the catheter having a lumen enabling both antegrade and retrograde flow within the lumen, the catheter for operative connection to a pump and controller, the pump and controller for providing selective antegrade flow through the catheter and selective retrograde flow through the catheter at different times during an endovascular procedure where antegrade flow supports collateral perfusion and retrograde flow removes a clot, wherein the controller has means for:

a. selectively providing antegrade flow through the catheter at a pressure to maintain perfusion pressure;

b. selectively providing retrograde flow through the catheter at a pressure sufficient to hold and/or withdraw a blood clot through the catheter;

c. inputting the size of the patient's internal carotid artery and the size of the catheter; and

d. inputting any one of or combination of:

i. degree of isolation of circulation;

ii. size of a microcatheter within the catheter;

iii. degree of tortuousity of the patient's vasculature;

iv. systemic blood pressure; and

v. properties of fluid being injected;

e. calculating a flow rate of fluid through the catheter sufficient to maintain perfusion pressure based on data from step c; and

f. pumping the fluid into the catheter at a flow rate calculated in step e.

2. The system as in claim 1 , further comprising a fluid supply operatively connected to the pump and controller, where the fluid supply includes anyone of or a combination of isotonic solutions supporting neuron viability including anyone of or a combination of nutrient rich fluids, viscosity reducing fluids, free radical scavengers, neuroprotectants, blood and/or flushing agents.

3. A system to maintain and/or enhance perfusion pressure in a patient with acute stroke and having relatively isolated circulation during an endovascular procedure as a catheter is advancing within the internal carotid artery, the system comprising:

a pump and controller;

a catheter configured to be arranged within the internal carotid artery, the catheter having a lumen enabling antegrade flow and retrograde flow within the lumen, the catheter being connected to the pump and controller, the pump and controller being configured to select antegrade flow through the catheter and select retrograde flow through the catheter at different times during an endovascular procedure, wherein the antegrade flow supports collateral perfusion and the retrograde flow removes a clot, wherein the controller has a means for receiving a size of the internal carotid artery of the patient and the size of the catheter as input.

4. A system as in claim 3 , wherein the controller is configured to calculate a flow rate of fluid through the catheter sufficient to maintain perfusion pressure based on the input.

5. A system to maintain and/or enhance perfusion pressure in a patient with acute stroke and having relatively isolated circulation during an endovascular procedure as a catheter is advancing within the internal carotid artery, the system comprising:

a catheter adapted for placement within the internal carotid artery, the catheter having a lumen enabling both antegrade and retrograde flow within the lumen, the catheter for operative connection to a pump and controller, the pump and controller for providing selective antegrade flow through the catheter and selective retrograde flow through the catheter at different times during an endovascular procedure where antegrade flow supports collateral perfusion and retrograde flow removes a clot, wherein the controller is configured to:

selectively provide antegrade flow through the catheter at a pressure to maintain perfusion pressure;

selectively provide retrograde flow through the catheter at a pressure sufficient to hold and/or withdraw a blood clot through the catheter;

receive the size of the internal carotid artery of the patient and the size of the catheter as input;

receive one or more of degree of isolation of circulation, size of a microcatheter within the catheter, degree of tortuousity of the patient's vasculature, systemic blood pressure; and properties of fluid being injected as input

calculate a flow rate of fluid through the catheter sufficient to maintain perfusion pressure based on the size of the internal carotid artery of the patient and the size of the catheter; and

pump the fluid into the catheter at the flow rate.

6. The system as in claim 5 , further comprising a fluid supply operatively connected to the pump and controller, where the fluid supply includes anyone of or a combination of isotonic solutions supporting neuron viability including anyone of or a combination of nutrient rich fluids, viscosity reducing fluids, free radical scavengers, neuroprotectants, blood and/or flushing agents.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2018
From: GOYAL, MAYANK
To: MG STROKE ANALYTICS INC.
Reel/Frame 047678/0712 →
Continuity (2)
Provisional Application 62267160 · Dec 14, 2015
Related Publication 20170164963A1 · Jun 15, 2017
Cited By (1)
US 12,622,712